0000902664-21-001835.txt : 20210310
0000902664-21-001835.hdr.sgml : 20210310
20210310194524
ACCESSION NUMBER: 0000902664-21-001835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Matrix Capital Management Company, LP
CENTRAL INDEX KEY: 0001410830
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 21731420
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: C/O MATRIX CAPITAL MANAGEMENT
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-522-4948
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: C/O MATRIX CAPITAL MANAGEMENT
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER NAME:
FORMER CONFORMED NAME: Matrix Capital Management Company, LLC
DATE OF NAME CHANGE: 20070827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOEL DAVID E.
CENTRAL INDEX KEY: 0001548144
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 21731421
MAIL ADDRESS:
STREET 1: C/O MATRIX CAPITAL MANAGEMENT CO., LP
STREET 2: 1000 WINTER STREET, SUITE 4500
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
ownership.xml
X0306
4
2021-03-08
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001548144
GOEL DAVID E.
C/O MATRIX CAPITAL MANAGEMENT CO., LP
1000 WINTER STREET, SUITE 4500
WALTHAM
MA
02451
1
0
0
1
See Remarks
0001410830
Matrix Capital Management Company, LP
1000 WINTER STREET
C/O MATRIX CAPITAL MANAGEMENT
WALTHAM
MA
02451
1
0
0
1
See Remarks
Common Stock
2021-03-08
4
S
0
234295
38.2181
D
12880795
I
See footnotes
Common Stock
2021-03-08
4
S
0
75000
39.2155
D
12805795
I
See footnotes
Common Stock
2021-03-08
4
S
0
33600
39.9714
D
12772195
I
See footnotes
Common Stock
2021-03-08
4
S
0
71194
41.2063
D
12701001
I
See footnotes
Common Stock
2021-03-08
4
S
0
85911
41.6216
D
12615090
I
See footnotes
Common Stock
2021-03-09
4
S
0
215698
40.4238
D
12399392
I
See footnotes
Common Stock
2021-03-09
4
S
0
34302
41.1605
D
12365090
I
See footnotes
Common Stock
2021-03-10
4
S
0
25732
41.4673
D
12339358
I
See footnotes
Common Stock
2021-03-10
4
S
0
30268
42.3769
D
12309090
I
See footnotes
Common Stock
1504
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.8275 to $38.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.83 to $39.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.845 to $40.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.49 to $41.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.495, to $41.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40 to $41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.005 to $41.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41 to $42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.01 to $42.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the
"Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the
Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.
The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Goel currently serves on the board of directors of the Issuer.
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner
2021-03-10
/s/ David E. Goel
2021-03-10